CL2015003780A1 - Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. - Google Patents
Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes.Info
- Publication number
- CL2015003780A1 CL2015003780A1 CL2015003780A CL2015003780A CL2015003780A1 CL 2015003780 A1 CL2015003780 A1 CL 2015003780A1 CL 2015003780 A CL2015003780 A CL 2015003780A CL 2015003780 A CL2015003780 A CL 2015003780A CL 2015003780 A1 CL2015003780 A1 CL 2015003780A1
- Authority
- CL
- Chile
- Prior art keywords
- bacterial
- pyrimido
- isoquinolin
- tautomers
- farm
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2015003780A CL2015003780A1 (es) | 2015-12-30 | 2015-12-30 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. |
| CN201680081761.1A CN109121411B (zh) | 2015-12-30 | 2016-12-29 | 嘧啶并-异喹啉-醌衍生的化合物、含有它们的药物组合物和它们在细菌性疾病治疗中的用途 |
| EP16880235.3A EP3404026B1 (en) | 2015-12-30 | 2016-12-29 | Pyrimido-isoquinolin-quinone derivative compounds, and pharmaceutically acceptable salts, isomers and tautomers thereof; pharmaceutical composition; preparation method; and use thereof in the treatment of diseases caused by bacteria and multidrug-resistant bacteria |
| US16/067,033 US11390622B2 (en) | 2015-12-30 | 2016-12-29 | Pyrimido-isoquinolin-quinone derivative compounds, and pharmaceutically acceptable salts, isomers and tautomers thereof; pharmaceutical composition; preparation method; and use thereof in the treatment of diseases caused by bacteria and multidrug-resistant bacteria |
| MX2018008192A MX2018008192A (es) | 2015-12-30 | 2016-12-29 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmaceuticamente aceptables; composicion farmaceutica; procedimiento de preparacion; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. |
| ES16880235T ES2951489T3 (es) | 2015-12-30 | 2016-12-29 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticamente aceptables; composición farmacéutica; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes |
| PCT/CL2016/050080 WO2017113031A1 (es) | 2015-12-30 | 2016-12-29 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticamente aceptables; composición farmacéutica; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2015003780A CL2015003780A1 (es) | 2015-12-30 | 2015-12-30 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2015003780A1 true CL2015003780A1 (es) | 2016-09-16 |
Family
ID=57234031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2015003780A CL2015003780A1 (es) | 2015-12-30 | 2015-12-30 | Compuestos derivados pirimido-isoquinolin-quinonas, sus sales, isomeros, tautomeros farmacéuticas aceptables; composiciones farmáceuticas; procedimiento de preparación; y su uso en el tratamiento de enfermedades bacterianas y bacterianas multirresistentes. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11390622B2 (es) |
| EP (1) | EP3404026B1 (es) |
| CN (1) | CN109121411B (es) |
| CL (1) | CL2015003780A1 (es) |
| ES (1) | ES2951489T3 (es) |
| MX (1) | MX2018008192A (es) |
| WO (1) | WO2017113031A1 (es) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0210028A (pt) | 2001-06-19 | 2004-06-22 | Warner Lambert Co | Agentes antibacterianos |
| DE10341614A1 (de) | 2003-09-10 | 2005-04-28 | Basf Ag | Verfahren zur Herstellung von Xylylendiamin (XDA) |
| MXPA06005550A (es) | 2003-11-18 | 2006-08-17 | Warner Lambert Co | Agentes antibacterianos. |
-
2015
- 2015-12-30 CL CL2015003780A patent/CL2015003780A1/es unknown
-
2016
- 2016-12-29 ES ES16880235T patent/ES2951489T3/es active Active
- 2016-12-29 CN CN201680081761.1A patent/CN109121411B/zh active Active
- 2016-12-29 US US16/067,033 patent/US11390622B2/en active Active
- 2016-12-29 EP EP16880235.3A patent/EP3404026B1/en active Active
- 2016-12-29 MX MX2018008192A patent/MX2018008192A/es unknown
- 2016-12-29 WO PCT/CL2016/050080 patent/WO2017113031A1/es active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| EP3404026A1 (en) | 2018-11-21 |
| MX2018008192A (es) | 2018-11-09 |
| ES2951489T3 (es) | 2023-10-23 |
| US11390622B2 (en) | 2022-07-19 |
| EP3404026A4 (en) | 2019-11-27 |
| WO2017113031A1 (es) | 2017-07-06 |
| CN109121411A (zh) | 2019-01-01 |
| US20190367505A1 (en) | 2019-12-05 |
| EP3404026B1 (en) | 2023-03-15 |
| CN109121411B (zh) | 2021-01-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SV2018005610A (es) | Derivados de oxopiridina sustituidos | |
| CO2017004525A2 (es) | Dihidropirrolopiridinas inhibidoras de ror-gamma | |
| DOP2016000271A (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados | |
| CL2016001895A1 (es) | Compuestos | |
| CL2018002814A1 (es) | Composiciones y metodos para el tratamiento de heridas, trastornos, y enfermedades de la piel. | |
| WO2015153959A3 (en) | Small molecule inhibitors of mcl-1 and uses thereof | |
| MX2016016666A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| MX2016015093A (es) | Derivados de acido boronico y sus usos terapeuticos. | |
| CL2016002072A1 (es) | 2-amino-3,5,5-trifluoro-3,4,5,6-tetrahidropiridinas como inhibidores de bace1 para el tratamiento de la enfermedad de alzheimer | |
| DOP2016000109A (es) | Formas sólidas de ácido {[5-(3-clorofenil) -3-hidroxipiridin-2-carbonil] amino} acético, composiciones, y usos de las mismas. | |
| UA116648C2 (uk) | Фумарати як проліки та їх застосування при лікуванні різних захворювань | |
| CO2017007121A2 (es) | Compuestos bicíclicos fusionados para el tratamiento de enfermedades | |
| CL2016002091A1 (es) | Compuesto de triazina y su uso para fines medicinales | |
| BR112016018062A2 (pt) | compostos terapêuticos, composição farmacêutica e usos | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| UY35747A (es) | Derivados sustituidos de fenilalanina | |
| DK3709978T3 (da) | Farmaceutisk oral formulering omfattende bakterier | |
| EP3231436A4 (en) | Pharmaceutical composition for prevention or treatment of metabolic disease, comprising bacteroides acidifaciens as effective ingredient | |
| BR112017013012A2 (pt) | compostos de indenil, composições farmacêuticas e usos médicos destes | |
| UY35745A (es) | Derivados sustituidos de fenilalanina | |
| DK3452465T3 (da) | Substituerede 2,4-diaminoquinolinderivater til anvendelse til behandling af proliferative sygdomme | |
| WO2015179823A3 (en) | Lung localized inhibitors of alpha(v)beta 6 | |
| UY37671A (es) | N-ariletil-2-aminoquinolin-4-carboxamidas sustituidas y su uso | |
| CL2016002321A1 (es) | Compuestos derivados del ácido 2-8-5-cloropirimidin-2-ilamino-6,7,8,9-tetrahidro-5h-pirido3,2-bindol-5-ilacético, moduladores del receptor de prostaglandina d2 composición farmacéutica y su uso para el tratamiento de enfermedadestrastornos alérgicosinmunitarios. | |
| IT201600081379A1 (it) | Composizione farmaceutica per uso nel trattamento delle patologie prostatiche. |